0001179110-19-002262.txt : 20190221
0001179110-19-002262.hdr.sgml : 20190221
20190221174119
ACCESSION NUMBER: 0001179110-19-002262
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190220
FILED AS OF DATE: 20190221
DATE AS OF CHANGE: 20190221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WALSH MATTHEW M
CENTRAL INDEX KEY: 0001269428
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36867
FILM NUMBER: 19623113
MAIL ADDRESS:
STREET 1: ALLERGAN
STREET 2: 5 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allergan plc
CENTRAL INDEX KEY: 0001578845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
CITY: COOLOCK, DUBLIN
STATE: L2
ZIP: D17 E400
BUSINESS PHONE: (216) 523-5000
MAIL ADDRESS:
STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
CITY: COOLOCK, DUBLIN
STATE: L2
ZIP: D17 E400
FORMER COMPANY:
FORMER CONFORMED NAME: Actavis plc
DATE OF NAME CHANGE: 20130930
FORMER COMPANY:
FORMER CONFORMED NAME: Actavis Ltd
DATE OF NAME CHANGE: 20130607
4
1
edgar.xml
FORM 4 -
X0306
4
2019-02-20
0
0001578845
Allergan plc
AGN
0001269428
WALSH MATTHEW M
CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
DUBLIN
L2
D17 E400
IRELAND
0
1
0
0
EVP, Chief Financial Officer
Ordinary Shares, Par value $0.0001
2019-02-20
4
F
0
2235
140.33
D
24181
D
Includes restricted stock units issued pursuant to the Amended and Restated Allergan, Inc. 2011 Incentive Award Plan.
/s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person
2019-02-21
EX-24.EX 24
2
ex24walsh.txt
WALSH UPDATED POA
SECTION 16 POWER OF ATTORNEY
With respect to holdings of and transactions in
securities issued by Allergan plc (the "COMPANY"), the
undersigned hereby constitutes and appoints the individuals named
on SCHEDULE A attached hereto and as may be amended from time to
time, or any of them signing singly, with full power of
substitution and resubstitution, to act as the undersigned's true
and lawful attorney-in-fact to:
1. prepare, execute in the undersigned's name and on
the undersigned's behalf, and submit to the United States
Securities and Exchange Commission (the "SEC") a Form ID,
including amendments thereto, and any other documents necessary
or appropriate to obtain and/or regenerate codes and passwords
enabling the undersigned to make electronic filings with the SEC
of reports required by Section 16(a) of the Securities Exchange
Act of 1934, as amended, or any rule or regulation of the SEC;
2. execute for and on behalf of the undersigned, Forms
3, 4, and 5 in accordance with Section 16 of the Securities
Exchange Act of 1934, as amended, and the rules thereunder;
3. do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Form 3, 4, or 5, complete and execute any
amendment or amendments thereto, and timely file such form with
the SEC and any stock exchange or similar authority; and
4. take any other action of any type whatsoever in
connection with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the best interest of,
or legally required by, the undersigned, it being understood that
the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as such
attorney-in-fact may approve in his or her discretion.
The undersigned hereby grants to each such attorney-in-
fact full power and authority to do and perform any and every act
and thing whatsoever requisite, necessary, or proper to be done
in the exercise of any of the rights and powers herein granted,
as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution
and resubstitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorneys-in-fact
substitute or substitutes, shall lawfully do or cause to be done
by virtue of this Power of Attorney and the rights and powers
herein granted.
The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of
the undersigned, are not assuming, nor is any Company assuming,
any of the undersigned's responsibilities to comply with Section
16 of the Securities Exchange Act of 1934, as amended.
This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file Forms
3, 4, and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
[SIGNATURE PAGE FOLLOWS]
IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this 3rd day of May 2018.
/s/ Matthew Walsh___
NAME: Matthew Walsh
TITLE: EVP & Chief Financial Officer
[SIGNATURE PAGE TO SECTION 16 POWER OF ATTORNEY]
SCHEDULE A
Individuals Appointed as Attorney-in-Fact with Full Power of
Substitution and Resubstitution
A. Robert D. Bailey, EVP & Chief Legal Officer and Corporate
Secretary
Matthew Walsh, EVP & Chief Financial Officer
James D'Arecca, SVP, Chief Accounting Officer - Global
Kira Schwartz, Assistant Secretary